An early endosome regulator, Rab5b, is an LRRK2 kinase substrate

Journal of Biochemistry

Volumn 157, Issue 6, 2015, Pages 485-495

  Yun, Hye Jin ^a,d   Kim, Hyejung ^b   Ga, Inhwa ^b   Oh, Hakjin ^b   Ho, Dong Hwan ^b,c   Kim, Jiyoung ^b   Seo, Hyemyung ^c   Son, Ilhong ^b,d   Seol, Wongi ^a,b  

^a Inje University   (South Korea)

^b Wonkwang University   (South Korea)

^c Hanyang University   (South Korea)

^d Kosin University   (South Korea)

Author keywords

GTPase activity; Kinase substrate; LRRK2; Parkinson's disease; Rab5

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LEUCINE RICH REPEAT KINASE 2; RAB PROTEIN; RAB5B PROTEIN; RECOMBINANT PROTEIN; REGULATOR PROTEIN; THREONINE; UNCLASSIFIED DRUG; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; RAB5C PROTEIN, HUMAN;

ARTICLE; CELL FUSION; CELL MOTILITY; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HUMAN; IN VITRO STUDY; MASS SPECTROMETRY; NERVE FIBER GROWTH; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; WESTERN BLOTTING; ENZYME SPECIFICITY; HEK293 CELL LINE; METABOLISM; MOLECULAR MIMICRY; PHOSPHORYLATION;

ENDOSOMES; GTP PHOSPHOHYDROLASES; HEK293 CELLS; HUMANS; MOLECULAR MIMICRY; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RAB5 GTP-BINDING PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUBSTRATE SPECIFICITY;

EID: 84939610945     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvv005     Document Type: Article

References (56)

1. Lubbe, S. and Morris, H.R. (2014) Recent advances in Parkinson's disease genetics. J. Neurol. 261, 259-266
2. Paisan-Ruiz, C, Jain, S., Evans, E.W., Gilks, W.P., Simon, J., van der Brug, M., Lopez de Munain, A., Aparicio, S., Gil, A.M., Khan, N., Johnson, J., Martinez, J.R., Nicholl, D., Carrera, I.M., Pena, A.S., de Silva, R., Lees, A., Marti-Masso, J.F., Perez-Tur, J., Wood, N.W., and Singleton, A.B. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600
3. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B., Stoessl, A.J., Pfeiffer, R.F., Patenge, N., Carbajal, I.C., Vieregge, P., Asmus, F., Muller-Myhsok, B., Dickson, D.W., Meitinger, T., Strom, T.M., Wszolek, Z.K., and Gasser, T. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607
4. Zabetian, C.P., Samii, A., Mosley, A.D., Roberts, J.W., Leis, B.C., Yearout, D., Raskind, W.H., and Griffith, A. (2005) A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 65, 741-744
5. Healy, D.G., Falchi, M., O'Sullivan, S.S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C.P., Goldwurm, S., Ferreira, J.J., Tolosa, E., Kay, D.M., Klein, C, Williams, D.R., Marras, C, Lang, A.E., Wszolek, Z.K., Berciano, J., Schapira, A.H., Lynch, T., Bhatia, K.P., Gasser, T., Lees, A.J., and Wood, N.W. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol. 7, 583-590
6. Gloeckner, C.J., Kinkl, N., Schumacher, A., Braun, R.J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H., and Ueffing, M. (2006) The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet. 15, 223-232
7. West, A.B., Moore, D.J., Choi, C, Andrabi, S.A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K.L., Dawson, V.L., and Dawson, T.M. (2007) Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16, 223-232
8. Smith, W.W., Pei, Z., Jiang, H., Dawson, V.L., Dawson, T.M., and Ross, CA. (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat. Neurosci. 9, 1231-1233
9. Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M.P., Beilina, A., Blackinton, J., Thomas, K.J., Ahmad, R., Miller, D.W., Kesavapany, S., Singleton, A., Lees, A., Harvey, R.J., Harvey, K, and Cookson, M.R. (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol. Dis. 23, 329-341
10. Heo, H.Y., Park, J.M., Kim, C.H., Han, B.S., Kim, K.S., and Seol, W. (2010) LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity. Exp. Cell Res. 316, 649-656
11. MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K, and Abeliovich, A. (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52, 587-593
12. Plowey, E.D., Cherra, S.J. 3rd, Liu, Y.J., and Chu, CT. (2008) Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J. Neurochem. 105, 1048-1056
13. Orenstein, S.J., Kuo, S.H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., Cortes, E., Honig, L.S., Dauer, W., Consiglio, A., Raya, A., Sulzer, D., and Cuervo, A.M. (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 16, 394-406
14. Jaleel, M., Nichols, R.J., Deak, M., Campbell, D.G, Gillardon, F., Knebel, A., and Alessi, D.R. (2007) LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem. J. 405, 307-317
15. Skibinski, G, Nakamura, K, Cookson, M.R., and Finkbeiner, S. (2014) Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J. Neurosci. 34, 418-433
16. Parisiadou, L., Xie, C, Cho, H.J., Lin, X., Gu, X.L., Long, C.X., Lobbestael, E., Baekelandt, V., Taymans, J.M., Sun, L., and Cai, H. (2009) Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J. Neurosci. 29, 13971-13980
17. Imai, Y., Gehrke, S., Wang, H.Q., Takahashi, R., Hasegawa, K, Oota, E., and Lu, B. (2008) Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO. J. 27, 2432-2443
18. Gillardon, F. (2009) Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability-a point of convergence in Parkinsonian neurodegeneration? J. Neurochem. 110, 1514-1522
19. Yun, H.J., Park, J., Ho, D.H., Kim, H., Kim, C.H., Oh, H., Ga, I., Seo, H, Chang, S., Son, I., and Seol, W. (2013) LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25. Exp. Mol. Med. 45, e36
20. Xiong, Y., Yuan, C, Chen, R., Dawson, T.M., and Dawson, V.L. (2012) ArfGAP1 is a GTPase activating protein for LRRK2: reciprocal regulation of ArfGAP1 by LRRK2. J. Neurosci. 32, 3877-3886
21. Stafa, K, Trancikova, A., Webber, P.J., Glauser, L., West, A.B., and Moore, D.J. (2012) GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1. PLoS Genet. 8, e1002526
22. Bailey, R.M., Covy, J.P., Melrose, H.L., Rousseau, L., Watkinson, R., Knight, J., Miles, S., Farrer, M.J., Dickson, D.W., Giasson, B.I., and Lewis, J. (2013) LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathol. 126, 809-827
23. Gloeckner, C.J., Schumacher, A., Boldt, K, and Ueffing, M. (2009) The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro. J. Neurochem. 109, 959-968
24. Ohta, E., Kawakami, F., Kubo, M., and Obata, F. (2011) LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations. FEBS Lett. 585, 2165-2170
25. Martin, I., Kim, J.W., Lee, B.D., Kang, H.C., Xu, J.C., Jia, H., Stankowski, J., Kim, M.S., Zhong, J., Kumar, M., Andrabi, S.A., Xiong, Y., Dickson, D.W., Wszolek, Z.K., Pandey, A., Dawson, T.M., and Dawson, V.L. (2014) Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell 157, 472-485
26. Kumar, A., Greggio, E., Beilina, A., Kaganovich, A., Chan, D., Taymans, J.M., Wolozin, B., and Cookson, M.R. (2010) The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS ONE 5, e8730
27. Rideout, H.J. and Stefanis, L. (2014) The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease. Neurochem. Res. 39, 576-592
28. Deng, J., Lewis, P.A., Greggio, E., Sluch, E., Beilina, A., and Cookson, M.R. (2008) Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc. Natl Acad. Sci. USA 105, 1499-1504
29. Guo, L., Gandhi, P.N., Wang, W., Petersen, R.B., Wilson-Delfosse, A.L., and Chen, S.G (2007) The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp. Cell Res. 313, 3658-3670
30. Liao, J., Wu, C.X., Burlak, C, Zhang, S., Sahm, H., Wang, M., Zhang, Z.Y., Vogel, K.W., Federici, M., Riddle, S.M., Nichols, R.J., Liu, D., Cookson, M.R., Stone, T.A., and Hoang, Q.Q. (2014) Parkinson disease-associated mutation R1441H in LRRK2 prolongs the 'active state' of its GTPase domain. Proc. Natl Acad. Sci. USA 111, 4055-4060
31. Li, X., Tan, Y.C., Poulose, S., Olanow, C.W., Huang, X.Y., and Yue, Z. (2007) Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J. Neurochem. 103, 238-247
32. Stenmark, H., Parton, R.G, Steele-Mortimer, O., Lutcke, A., Gruenberg, J., and Zerial, M. (1994) Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J. 13, 1287-1296
33. Shin, N., Jeong, H., Kwon, J., Heo, H.Y., Kwon, J.J., Yun, H.J., Kim, C.H., Han, B.S., Tong, Y., Shen, J., Hatano, T., Hattori, N., Kim, K.-S., Chang, S., and Seol, W. (2008) LRRK2 regulates synaptic vesicle endocytosis. Exp. Cell Res. 314, 2055-2065
34. Nichols, R.J., Dzamko, N, Hutti, J.E., Cantley, L.C., Deak, M., Moran, J., Bamborough, P., Reith, A.D., and Alessi, D.R. (2009) Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem. J. 424, 47-60
35. Tremblay, R.G., Sikorska, M., Sandhu, J.K., Lanthier, P., Ribecco-Lutkiewicz, M., and Bani-Yaghoub, M. (2010) Differentiation of mouse Neuro 2A cells into dopamine neurons. J. Neurosci. Methods 186, 60-67
36. Kim, H.J., Zhong, Q., Sheng, Z.H., Yoshimori, T., Liang, C, and Jung, J.U. (2012) Beclin-1-interacting autophagy protein Atg14L targets the SNARE-associated protein Snapin to coordinate endocytic trafficking. J. Cell Sci. 125, 4740-4750
37. Pungaliya, P.P., Bai, Y., Lipinski, K., Anand, V.S., Sen, S., Brown, E.L., Bates, B., Reinhart, P.H., West, A.B., Hirst, W.D., and Braithwaite, S.P. (2010) Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motif. PLoS ONE 5, e13672
38. Angeles, D.C., Gan, B.H., Onstead, L., Zhao, Y., Lim, K.L., Dachsel, J., Melrose, H, Farrer, M., Wszolek, Z.K., Dickson, D.W., and Tan, E.K. (2012) Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Hum. Mutat. 32, 1390-1397
39. Lobbestael, E., Baekelandt, V., and Taymans, J.M. (2012) Phosphorylation of LRRK2: from kinase to substrate. Biochem. Soc. Trans. 40, 1102-1110
40. Hoffenberg, S., Sanford, J.C., Liu, S., Daniel, D.S., Tuvin, M., Knoll, B.J., Wessling-Resnick, M., and Dickey, B.F. (1995) Biochemical and functional characterization of a recombinant GTPase, Rab5, and two of its mutants. J. Biol. Chem. 270, 5048-5056
41. Li, G and Stahl, P.D. (1993) Structure-function relationship of the small GTPase rab5. J. Biol. Chem. 268, 24475-24480
42. Liu, J., Lamb, D., Chou, M.M., Liu, Y.J., and Li, G (2007) Nerve growth factor-mediated neurite outgrowth via regulation of Rab5. Mol. Biol. Cell 18, 1375-1384
43. Chiariello, M., Bruni, C.B., and Bucci, C. (1999) The small GTPases Rab5a, Rab5b and Rab5c are differentially phosphorylated in vitro. FEBS Lett. 453, 20-24
44. Sun, P., Yamamoto, H, Suetsugu, S., Miki, H, Takenawa, T., and Endo, T. (2003) Small GTPase Rah/Rab34 is associated with membrane ruffles and macropinosomes and promotes macropinosome formation. J. Biol. Chem. 278, 4063-4071
45. Greggio, E., Lewis, P.A., van der Brug, M.P., Ahmad, R., Kaganovich, A., Ding, J., Beilina, A., Baker, A.K., and Cookson, M.R. (2007) Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1. J. Neurochem. 102, 93-102
46. Li, G, Barbieri, M.A., Colombo, M.I., and Stahl, P.D. (1994) Structural features of the GTP-binding defective Rab5 mutants required for their inhibitory activity on endocytosis. J. Biol. Chem. 269, 14631-14635
47. Bucci, C, Parton, R.G, Mather, I.H., Stunnenberg, H, Simons, K., Hoflack, B., and Zerial, M. (1992) The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70, 715-728
48. Chen, X. and Wang, Z. (2001) Regulation of epidermal growth factor receptor endocytosis by wortmannin through activation of Rab5 rather than inhibition of phosphatidylinositol 3-kinase. EMBO Rep. 2, 842-849
49. Dong, Y., Heien, M.L., Maxson, M.M., and Ewing, A.G (2008) Amperometric measurements of catecholamine release from single vesicles in MN9D cells. J. Neurochem. 107, 1589-1595
50. Heo, H.Y., Kim, K.S., and Seol, W. (2010) Coordinate regulation of neurite outgrowth by LRRK2 and its interactor, Rab5. Exp. Neurobiol. 19, 97-105
51. Stafa, K., Tsika, E., Moser, R., Musso, A., Glauser, L., Jones, A., Biskup, S., Xiong, Y., Bandopadhyay, R., Dawson, V.L., Dawson, T.M., and Moore, D.J. (2013) Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase super-family. Hum. Mol. Genet. 15, 2055-2077
52. Ding, J., Soule, G., Overmeyer, J.H., and Maltese, W.A. (2003) Tyrosine phosphorylation of the Rab24 GTPase in cultured mammalian cells. Biochem. Biophys. Res. Commun. 312, 670-675
53. Fitzgerald, M.L. and Reed, G.L. (1999) Rab6 is phosphorylated in thrombin-activated platelets by a protein kinase C-dependent mechanism: effects on GTP/GDP binding and cellular distribution. Biochem. J. 342, 353-360
54. Haas, A.K., Fuchs, E., Kopajtich, R., and Barr, F.A. (2005) A GTPase-activating protein controls Rab5 function in endocytic trafficking. Nat. Cell Biol. 7, 887-893
55. Plowey, E.D. and Chu, C.T. (2010) Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy? Neurobiol. Dis. 43, 60-67
56. Gomez-Suaga, P., Rivero-Rios, P., Fdez, E., Blanca Ramirez, M., Ferrer, I., Aiastui, A., Lopez De Munain, A., and Hilfiker, S. (2014) LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum. Mol. Genet. 23, 6779-6796